WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years

Similar documents
Sperm Donation - Information for Donors

WHAT YOU NEED TO KNOW ABOUT DONATING SPERM, EGGS OR EMBRYOS

Your consent to donating your eggs

THE LAW - CONCEPTION USING DONOR EGGS OR SPERM

D D M M Y Y D D M M Y Y. For clinic use only (optional) MD PNT only (gender-neutral): version 1; 3 April 2017

Fill in this form if you are donating eggs and/or embryos created with your eggs for use in another person s mitochondrial donation

Men s consent to the use and storage of sperm or embryos for surrogacy

Guide to Good Practice in fertility cases

Your consent to the use of your sperm in artificial insemination

Your consent to your sperm and embryos being used in treatment and/or stored (IVF and ICSI)

Your consent to the storage of your eggs or sperm

Information For Egg Recipients

Women s consent to the use and storage of eggs or embryos for surrogacy

Introduction 4. Important information about consent to legal parenthood 7. Women s consent to treatment and storage form (IVF and ICSI) (WT form) 9

Withdrawing your consent

Your consent to disclosing identifying information

Regulating mitochondrial donation: seeking expert views. Background document

Fertility Policy. December Introduction

INTRACYTOPLASMIC SPERM INJECTION

HFEA SEED Review consultation: "Regulation of Donor Assisted Conception"

University of Huddersfield Repository

MST and PNT allow eggs or embryos to be created for you containing your and your partner s nuclear genetic material D D M M Y Y D D M M Y Y

Access to IVF. Help us decide Discussion paper. South Central Specialised Commissioning Group C - 1

Women s consent to treatment and storage form (IVF and ICSI)

Fertility treatment in trends and figures

North Staffordshire Clinical Commissioning Group. Infertility and Assisted Reproduction Commissioning Policy and Eligibility Criteria

Commissioning Policy For In Vitro Fertilisation (IVF) / Intracytoplasmic Sperm Injection (ICSI) within Tertiary Infertility Services

COMMISSIONING POLICY. Tertiary treatment for assisted conception services

Blyth, E. (2003) Access to information about gamete and embryo donors in the UK. Obs & Gynae Today VIII(3): (ISSN )

Approved January Waltham Forest CCG Fertility policy

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES V2.

Director of Commissioning, Telford and Wrekin CCG and Shropshire CCG. Version No. Approval Date August 2015 Review Date August 2017

Sperm Donation Patient Information Becoming a sperm donor

Policy updated: November 2018 (approved by Haringey and Islington s Executive Management Team on 5 December 2018)

15. Procuring, processing and transporting gametes and

National Gamete Donation Trust

Haringey CCG Fertility Policy April 2014

Transparency, Equity, Ethics: access to care. quality of life. Improving. and patients. An Agency of the French Ministry of Health

Assisted Reproductive Technologies

Bromley CCG Assisted Conception Funding Form Checklist for Eligibility Criteria for NHS funding of Assisted Conception

More Fun Than Giving Blood CLINIC RECRUITED

University of Huddersfield Repository

Anonymity in sperm donation: what do the numbers say?

Information for Egg Sharers

Recommended Interim Policy Statement 150: Assisted Conception Services

Paper. Donation review conditional donation. Hannah Darby, Policy Manager. Decision

STEM CELL RESEARCH: MEDICAL PROGRESS WITH RESPONSIBILITY

Couples Information Leaflet

WHAT IS A PATIENT CARE ADVOCATE?

Public consultation: Seeking your views on IVF

Fertility Services Commissioning Policy

SHIP8 Clinical Commissioning Groups Priorities Committee (Southampton, Hampshire, Isle of Wight and Portsmouth CCGs)

Blackpool CCG. Policies for the Commissioning of Healthcare. Assisted Conception

COMMISSIONING POLICY FOR IN VITRO FERTILISATION (IVF)/ INTRACYTOPLASMIC SPERM INJECTION (ICSI) WITHIN TERTIARY INFERTILITY SERVICES

GENA2. Source Booklet. General Studies (Specification A) General Certificate of Education Advanced Subsidiary Examination June 2011

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Intrauterine (IUI) and Donor Insemination (DI) Policy (excluding In vitro fertilisation (IVF) & Intracytoplasmic sperm injection (ICSI) treatment)

18 September 2015 FERTILITY ASSESSMENT AND TREATMENT AMENDMENT CONSULTATION

Class application to import donated gametes by a registered ART provider

Note: This updated policy supersedes all previous fertility policies and reflects changes agreed by BHR CCGs governing bodies in June 2017.

Policy statement. Commissioning of Fertility treatments

Assisted Conception Policy

Consent for In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), and Embryo Cryopreservation/Disposition

West Hampshire Clinical Commissioning Group Board

Human Fertilisation and Embryology Authority

17. Storage of gametes and embryos

ManorIVF Donor Egg Service to Australia

Submission to the Commission on Assisted Human Reproduction December 2001

HALTON CLINICAL COMMISSIONING GROUP NHS FUNDED TREATMENT FOR SUBFERTILITY. CONTENTS Page

Unit B2, B2.7. Cell division and inheritance. Stage 1. Ovary. Cell Q. Cell P. Cell R. Cell S. 7 Embryo A B C

Directions given under the Human Fertilisation and Embryology Act 1990 as amended. Ref: 0006 Version: 4

Human Fertilisation and Embryology Authority 10 Spring Gardens London SW1A 2BU t e w

CONSENT In Vitro Fertilization, Intracytoplasmic Sperm Injection, Assisted Hatching, and Embryo Cryopreservation/Disposition

European IVF Monitoring (EIM) Year: 2013

Round robin summary - March 2012 Co-payment for unlicensed drug Egg donation Recruitment and training of Lay members

Clinical Policy Committee

DRAFT Policy for the Provision of NHS funded Gamete Retrieval and Cryopreservation for the Preservation of Fertility

NHS FUNDED TREATMENT FOR SUBFERTILITY. ELIGIBILITY CRITERIA POLICY GUIDANCE/OPTIONS FOR CCGs

Placename CCG. Policies for the Commissioning of Healthcare. Policy for Assisted Conception Services

Fertility Services Commissioning Policy

East and North Hertfordshire CCG. Fertility treatment and referral criteria for tertiary level assisted conception

GOVERNING BOARD. Assisted Conception (IVF): Review of access criteria. Date of Meeting 21 January 2015 Agenda Item No 13. Title

Fertility treatment and referral criteria for tertiary level assisted conception

Fertility Services Commissioning Policy

IVF. NHS North West London CCGs

Infertility Counselling and Ethical Issues. Jennifer Hunt Wolfson Fertility Centre

PROGAR (British Association of Social Workers Project Group on Assisted Reproduction)

PROCEDURES LAPAROSCOPY

Fertility treatment in trends and figures

Friday, 13 January 2017 HFEA, 10 Spring Gardens, London SW1A 2BU

Fertility treatment and referral criteria for tertiary level assisted conception

Application to import or export donor sperm, eggs or embryos

Adverse incidents in fertility clinics: lessons to learn

Attitudes toward Egg Donation among Individuals with Infertility. Request for Cooperation

Clinical Policy Committee

Fertility Services Commissioning Policy (Level 3)

Financial Information for Patients Valid from 1 September Fertility Assessment and Consultations

Biology of fertility control. Higher Human Biology

Health Scrutiny Panel 6 February 2014

Opinion no. 67 of 12 September 2016 on the reception of eggs harvested from the partner within lesbian couples with a view to in vitro fertilisation

Transcription:

WHO ARE THE DONORS? - An HFEA Analysis of donor registrations and use of donor gametes over the last 10 years Page 1 of 9 05/29501

Trends in the use of donor gametes (sperm and eggs) Donor assisted conception is a relatively small, and declining, area of fertility treatment, particularly when compared to the fertility treatment carried out ten years ago In 2002-2003: 1 in 5 of licensed treatments (19.8%) involved the use of donor sperm [compared to almost half of treatments (46.9%) in 1994-95] 1 in 20 licensed treatments (4.9%) involved the use of donor eggs [compared to almost 1 in 35 of treatments (2.9%) in 1994-95] 1 in 8 children born through licensed fertility treatment (12.2%) was born from donated sperm this is equivalent to approximately 1 in 800 of all children born in the UK [compared to 1 in 3 (33.1%)in 1994-95] 1 in 16 children born through licensed fertility treatment (6.1%) was born from donated eggs equivalent to approximately 1 in 1600 of all children born in the UK [compared to 1 in 22 children (4.6%) in 1994-5] Advances in reproductive technology have meant that the demand for fertility treatment using donor gametes have declined considerably over the last 10 years. For example, the development of ICSI (intra-cytoplasmic sperm injection) has led to a significant fall in the need for donor sperm. This involves injecting a single sperm directly into the centre of an egg which is then placed in a woman s body using conventional IVF methods. ICSI is especially effective for men who have a low sperm count, have had a vasectomy or in cases where the sperm have difficulty swimming (low motility) or penetrating the egg. Prior to ICSI, couples where this problem had been identified would have been most likely to be treated using donor sperm. The graph below shows how the number of donor insemination treatments has fallen over the last 10 years, while the number of treatments using ICSI has risen steadily. During 1992-93 there were more than 25,000 donor insemination treatments (using donor sperm), this had fallen to little over 6,000 treatments by 2003-03. While during this period the number of ICSI treatments had risen from nearly zero in 1992-93 to more than 15,000 in 2002-03. Page 2 of 9 05/29501

DI and ICSI treatment numbers 30000 25000 Donor Insemination Micromanipulation (ICSI) 20000 number of treatments 15000 10000 5000 0 92-93 93-94 94-95 95-96 96-97 97-98 98-99 99-00 00-01 01-02 02-03 date Treatment using donor gametes who s who in the system A number of clinics across the UK have developed a particular speciality in recruiting sperm and egg donors (referred to as the recruiting centre ) and it is common for sperm and egg donations to be made at a different clinic to the centre where a couple are receiving treatment using the donation (the treatment centre ). The recruitment of donors is the responsibility of recruiting centres, working within the law (the Human Fertilisation and Embryology Act 1990) and the detailed guidelines produced by the HFEA. A national charity called the National Gamete Donation Trust (NGDT) exists to encourage people to come forward as donors, encouraging the supply of donated sperm, eggs and embryos and acts as a central reference point for donors, recipients and health professionals. The HFEA, as fertility regulator, acts to ensure that donation and treatment using donor sperm eggs and embryos is carried out in a safe and appropriate way. Our role is also to make sure that the system is as simple and easy to administer as possible. We are also required to keep details of every donor and every treatment using donor eggs, sperm or embryos (see below). The HFEA has no responsibility for the supply of donor gametes. Page 3 of 9 05/29501

Information about donors Since 1 July 1991, when the formal UK fertility regulation system was set up, details of all sperm, egg and embryo donors must be registered with the HFEA. The HFEA s Register has been in place since the HFEA was set up in 1991 and contains information about all sperm, egg and embryo donors. Prior to April 2005, in accordance with the HFE Act 1990, people were permitted to ask the HFEA: From the age of 18 - Whether they were born as a result of treatment with donor sperm, eggs or embryo and obtain non-identifying information about the donor From the age of 16 - people could ask whether they could be genetically related to someone they intend to marry The information that donors have given to the HFEA has included their name and address. They have also given a range of other information which may include sex, height, weight, ethnic group, eye colour, hair colour, skin colour, year of birth, country of birth, marital status, ethnic group of parents whether the donors were adopted, whether the donor has children of their own and if so, the number and sex of these screening tests carried out on the donor and information about their personal and family medical history the religion, occupation interests and skills of the donor, and their reason for donating a pen-portrait of themselves as a person and a goodwill message to the future children Note: not all donors have supplied all of this information If the donor registered before 1 April 2005, the law says that the child born as a result of the donation is NOT allowed to know the name and address of the donor. This law is not retrospective. However, the donor re-registers as an identifiable donor after 1 April 2005; any child born as a result of their donation has the right to access identifying information about the donor when they reach the age of 18. This new legislation was passed by Parliament in 2004 following two years of consultation with clinics, donors and voluntary organisations which highlighted that many donor-conceived people wanted the option of finding out their biological background. From 1 April 2005 onwards, children born through donation are able to find out: The donor s name, name at birth if different and address The donor s date of birth and the town or district of birth The appearance of the donor Treatment centres had until 1 April 2006 to use their stocks of non-identifiable donor eggs and sperm. Donors themselves are able to apply to the HFEA to find out what happened following their donation. Donors can be told: How many children have been born as a result of their donation How many of these children are boys and how many are girls Which year the children were born in Page 4 of 9 05/29501

Donors The UK Picture Alongside the review of the Sperm, Egg and Embryo Donation system (the SEED review), the HFEA has carried out an initial analysis of the kind of people who are registering as sperm and egg donors. This has shown substantial change over the last 10 years with the stereotype of sperm donors being young students being far from the truth nowadays. In 2004-05: more than 2 out of 3 sperm donors (69%) were aged over 30 The most common age group for sperm donors is 36-40 more than 2 out of 5 sperm donors (41.5%) already have children of their own just under a third of sperm donors (31.4%) have two or more children While in 1994-1995: Sperm donors were most commonly aged between 18 24 years. Less than a third (32.2%) of sperm donors were over the age of 30 Only 1 in 5 (21%) of sperm donors already had children of their own. Number of existing children (sperm donors 2004-05) 4 0.0% 5 3.7% 3 11.1% 2 16.7% 0 55.6% 0 1 2 3 4 5 1 13.0% Page 5 of 9 05/29501

Age breakdown of sperm donors 94-95 and 04-05 50.0% 40.0% 30.0% 94-95 04-05 20.0% 10.0% 0.0% 18-24 25-30 31-35 36-40 41-45 >45 age group sperm donors with own children 94-95 sperm donors with own children 04-05 21% 41% 59% 79% Yes No Page 6 of 9 05/29501

The changes have been less marked in egg donors, with the age distribution of egg donors remaining relatively unchanged over the last 10 years Age breakdown of egg donors 94-95 and 04-05 60.0% 50.0% 40.0% 30.0% 94-95 04-05 20.0% 10.0% 0.0% 18-24 25-30 31-35 36-40 41-45 >45 age group However, the number of egg donors with children of their own has fallen substantially. This is probably due to the rise in the number of egg sharing schemes, where women donate their spare eggs at the same time as they receive fertility treatment themselves. Egg donors with own children 94-95 Egg donors with own children 04-05 20% 50% 50% 80% Yes No Page 7 of 9 05/29501

Key conclusions from the Sperm, Egg & Embryo Donation (SEED) Report Screening & selection of gamete donors The HFEA s current Code of Practice provides guidance to clinics on the screening of potential gamete donors and also informs clinics about sets of guidance from the relevant professional bodies in this area which clinics must adhere to. One of the key conclusions of the SEED report is that the HFEA should move towards a reliance on professional guidance on the medical and laboratory screening of sperm, egg and embryo donors when revised guidance becomes available. The relevant professional bodies have formed a joint committee and will be working together to produce one set of professional guidance on donor screening for clinics. This guidance will therefore be produced by those with the most expertise and direct experience, ensuring that donors continue to be screened to the highest possible standards. The SEED Report also concluded that the HFEA will not provide prescriptive guidance on the selection of donors for the treatment of a particular recipient. Instead, the HFEA will provide guidance on issues to be taken into account during selection - this will give clinics more freedom in selecting donors for individual treatments whilst still ensuring the wishes of the patient and partner have been taken into account and ultimately, the welfare of the child who may be born as a result of treatment. Compensation for donors The EU Tissue and Cells Directive sets out the underlying principle that all gamete donation should be voluntary and unpaid. Thus it was timely for the SEED Review to consider compensation for donors in the UK. With regard to issues of compensation and expenses the Authority has decided: Currently, donors may be reimbursed all reasonable, demonstrable out-of-pocket expenses incurred within the UK in connection with gamete or embryo donation this policy remains the same In addition to the above, the Authority has concluded that donors may be compensated for loss of earnings up to a daily maximum commensurate with jury service ( 55.19 per day) but with an overall limit of 250 for each course of sperm donation (3-4 months) or each cycle of egg donation. Gamete donors may receive benefits in kind in return for supplying gametes for the treatment of others but these benefits should be limited to discounted treatment services. Page 8 of 9 05/29501

The use of donor gametes Currently, an individual donor may only be used to produce 10 live birth events plus exceptions Singletons, twins, triplets or greater births all count as one live birth event. The most common exception is when there are more than 10 live birth events from a donor to provide genetically related brothers or sisters for children previously born from a donation. In addition, donors may set their own lower limits on the use their gametes which must not be exceeded. The Authority concluded that this guideline should be simplified and clarified so that the gametes of an individual donor may not be used to produce children for more than 10 families in the UK. This change was intended to make it clearer for donors in terms of how many families will be created as a result of their donation. In addition, it was thought to be beneficial in that it would allow a genetic link between sibling and half siblings in donor conceived families. Donors are still able to set their own limits on the use of their gametes which must not be exceeded. A new system of guidance has been introduced for clinics to help monitor the use of a donor s gametes to ensure better control on the use of the donation so the limits for their use will not be exceeded. As explained above, a donor can apply to the HFEA for details of the number of children born following their donation. Import of donor gametes from abroad UK regulation has set a high standard of quality in terms of the screening criteria for gamete donation and the requisite information that must be provided for each donor. The Authority felt that these standards should be maintained and that therefore the HFEA would expect to authorize the imports of gametes from abroad only where the same standards as are required in the UK can be met. Conclusion The outcomes of the SEED Review, made in the light of the public consultation, are there to ensure that UK regulation is brought into line with new standards coming from Europe and to continue to ensure that donor assisted conception continues to be safe, fair and effective for donors, recipients and donor-conceived children alike. Page 9 of 9 05/29501